Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
NRC 
National Research Corp (NRC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: NRC (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -37.76% | Avg. Invested days 28 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 294.16M USD | Price to earnings Ratio 12.33 | 1Y Target Price - |
Price to earnings Ratio 12.33 | 1Y Target Price - | ||
Volume (30-day avg) 96514 | Beta 0.49 | 52 Weeks Range 12.32 - 36.78 | Updated Date 04/1/2025 |
52 Weeks Range 12.32 - 36.78 | Updated Date 04/1/2025 | ||
Dividends yield (FY) 3.75% | Basic EPS (TTM) 1.04 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 17.32% | Operating Margin (TTM) 26.03% |
Management Effectiveness
Return on Assets (TTM) 17.28% | Return on Equity (TTM) 61.77% |
Valuation
Trailing PE 12.33 | Forward PE - | Enterprise Value 354337728 | Price to Sales(TTM) 2.07 |
Enterprise Value 354337728 | Price to Sales(TTM) 2.07 | ||
Enterprise Value to Revenue 2.48 | Enterprise Value to EBITDA 8.59 | Shares Outstanding 22945500 | Shares Floating 18915379 |
Shares Outstanding 22945500 | Shares Floating 18915379 | ||
Percent Insiders 38.29 | Percent Institutions 52.56 |
Analyst Ratings
Rating 4 | Target Price - | Buy 1 | Strong Buy - |
Buy 1 | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
National Research Corp
Company Overview
History and Background
National Research Corporation (NRC Health) was founded in 1981. It initially focused on patient satisfaction measurement and has since expanded to offer a range of healthcare intelligence solutions.
Core Business Areas
- Experience Solutions: Provides surveys, feedback, and data analytics to help healthcare organizations improve patient, employee, and consumer experience.
- Market Insights: Offers market research, competitive intelligence, and strategic planning services to healthcare providers and payers.
- Digital Experience: Helps organizations to develop and optimize their digital healthcare experiences.
Leadership and Structure
The company is led by a Board of Directors and an executive management team. Michael Hays is currently the CEO. The organizational structure is based on functional departments such as sales, marketing, product development, and finance.
Top Products and Market Share
Key Offerings
- Experience Solutions: Patient feedback surveys and analytics that enable healthcare providers to improve patient satisfaction, loyalty and advocacy. Competitors include Press Ganey, Advisory Board and Qualtrics. Market share difficult to calculate precisely, but NRC Health is considered a major player.
- Market Insights: Custom market research solutions, including market segmentation, brand awareness studies, and competitive analysis, helping healthcare organizations understand their markets and make informed strategic decisions. Competitors include Definitive Healthcare and Trilliant Health. Specific market share data not publicly available.
- Digital Experience: A variety of tools and tactics help healthcare systems improve their digital presence and experience including digital accessibility consulting, digital listening capabilities, and digital maturity assessment. Specific market share data not publicly available.
Market Dynamics
Industry Overview
The healthcare intelligence and analytics market is growing due to increasing demand for data-driven insights to improve patient care, operational efficiency, and financial performance. Key trends include the adoption of cloud-based solutions and the use of artificial intelligence and machine learning.
Positioning
NRC Health is positioned as a leading provider of experience management and market intelligence solutions for the healthcare industry. Its competitive advantages include its deep domain expertise, comprehensive data assets, and established client relationships.
Total Addressable Market (TAM)
The total addressable market for healthcare analytics is estimated to be in the tens of billions of dollars. NRC Health is positioned to capture a significant share of this market.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- Established client base
- Comprehensive suite of solutions
- Deep domain expertise
- Proprietary data assets
Weaknesses
- Reliance on healthcare industry trends
- Potential for commoditization of some services
- Slower growth compared to emerging tech companies
- Limited international presence
Opportunities
- Expansion into new healthcare verticals
- Development of new data-driven solutions
- Strategic acquisitions
- Increased adoption of cloud-based analytics
- Leveraging AI and machine learning
Threats
- Intense competition
- Data privacy and security concerns
- Changes in healthcare regulations
- Economic downturn
- Emergence of disruptive technologies
Competitors and Market Share
Key Competitors
- PGNY
- ADVY
- XM
Competitive Landscape
NRC Health competes with other healthcare intelligence and analytics providers, as well as consulting firms. Its strengths include its focus on patient experience and its established client relationships. Weaknesses include reliance on the healthcare industry and less aggressive innovation compared to smaller, nimbler firms.
Major Acquisitions
TransUnion Healthcare
- Year: 2022
- Acquisition Price (USD millions): 535
- Strategic Rationale: The strategic rationale behind the acquisition to expand its data and analytics capabilities and to provide a more comprehensive suite of solutions to its clients.
Growth Trajectory and Initiatives
Historical Growth: Needs to be populated with growth data based on past performance.
Future Projections: Needs to be populated with analyst estimate data.
Recent Initiatives: Needs to be populated with data about recent strategic initiatives.
Summary
NRC Health is a relatively stable company with a long history in the healthcare experience space. It benefits from strong client relationships and a respected brand. However, it faces increasing competition and must continue to innovate to maintain its market position and achieve stronger growth. Future success depends on leveraging its data assets and adapting to evolving healthcare trends.
Similar Companies
PGNY
Progyny Inc
PGNY
Progyny Inc
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Industry Reports
- Analyst Estimates
Disclaimers:
The data provided is for informational purposes only and should not be considered investment advice. Market share data is estimated and may not be precise. Financial data should be verified with official sources.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About National Research Corp
Exchange NASDAQ | Headquaters Lincoln, NE, United States | ||
IPO Launch date 1997-10-10 | Founder, CEO, President & Director Mr. Michael D. Hays | ||
Sector Healthcare | Industry Health Information Services | Full time employees 368 | Website https://www.nrchealth.com |
Full time employees 368 | Website https://www.nrchealth.com | ||
National Research Corporation provides analytics and insights that facilitate measurement and improvement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, rounding, and brand loyalty. The company also offers marketing experience solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools through a multi-mode digital platform. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; employee experience solutions that give care teams information, tools and support needed to create engagement and open communication throughout the employee lifecycle; and consumer experience solutions which capture feedback across the healthcare journey, drive choice to build volume, and co-design experiences and services through community insights. Additionally, the company offers Huey AI, an AI engine for Human Understanding that serves as a healthcare experience management companion; and governance solutions for not-for-profit health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.